IGF‐I regulates the age‐dependent signaling peptide humanin. Issue 5 (18th July 2014)

• Record Type: Journal Article
• Authors: Lee, Changhan; Wan, Junxiang; Miyazaki, Brian; Fang, Yimin; Guevara‐Aguirre, Jaime; Yen, Kelvin; Longo, Valter; Bartke, Andrzej; Cohen, Pinchas
• Is Part Of: Aging cell. Volume 13:Issue 5(2014:Oct.)
• Page Start: 958
• Page End: 961
• Publication Date: 2014-07-18
• Subjects: Cells -- Aging -- Periodicals; 571.8783605
• DOI: 10.1111/acel.12243
• Languages: English
• ISSNs: 1474-9718

Abstract

<abstract abstract-type="main" id="acel12243-abs-0001"> <title>Summary</title> <p>Aging is influenced by endocrine pathways including the growth hormone/insulin‐like growth factor‐1 (GH/IGF) axis. Mitochondrial function has also been linked to the aging process, but the relevant mitochondrial signals mediating the effects of mitochondria are poorly understood. Humanin is a novel signaling peptide that acts as a potent regulator of cellular stress responses and protects from a variety of <italic>in vitro</italic> and <italic>in vivo</italic> toxic and metabolic insults. The circulating levels of humanin decline with age in mice and humans. Here, we demonstrate a negative correlation between the activity of the GH‐IGF axis and the levels of humanin, as well as a positive correlation between humanin and lifespan in mouse models with altered GH/IGF‐I axis. Long‐lived, GH‐deficient Ames mice displayed elevated humanin levels, while short‐lived GH‐transgenic mice have reduced humanin levels. Furthermore, treatment with GH or IGF‐I reduced circulating humanin levels in both mice and human subjects. Our results indicate that GH and IGF are potent regulators of humanin levels and that humanin levels correlate with lifespan in mice. This suggests that humanin represents a circulating mitochondrial signal that participates in modulating the aging process, adding a coordinated mitochondrial element to the endocrine regulation of aging.</p> </abstract>